Free Trial

HCA Healthcare, Inc. (NYSE:HCA) Holdings Trimmed by State of Michigan Retirement System

HCA Healthcare logo with Medical background

State of Michigan Retirement System reduced its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 2.0% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 48,509 shares of the company's stock after selling 1,000 shares during the period. State of Michigan Retirement System's holdings in HCA Healthcare were worth $16,762,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of the stock. MJP Associates Inc. ADV purchased a new position in shares of HCA Healthcare during the 1st quarter valued at $222,000. Cerity Partners LLC grew its holdings in shares of HCA Healthcare by 9.7% during the 1st quarter. Cerity Partners LLC now owns 30,844 shares of the company's stock valued at $10,658,000 after acquiring an additional 2,718 shares in the last quarter. Alps Advisors Inc. lifted its stake in shares of HCA Healthcare by 44.9% in the 1st quarter. Alps Advisors Inc. now owns 1,332 shares of the company's stock valued at $460,000 after purchasing an additional 413 shares during the last quarter. Allworth Financial LP lifted its stake in shares of HCA Healthcare by 8.7% in the 1st quarter. Allworth Financial LP now owns 798 shares of the company's stock valued at $272,000 after purchasing an additional 64 shares during the last quarter. Finally, Capital Insight Partners LLC lifted its stake in shares of HCA Healthcare by 6.0% in the 1st quarter. Capital Insight Partners LLC now owns 3,878 shares of the company's stock valued at $1,340,000 after purchasing an additional 220 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

NYSE:HCA opened at $375.76 on Friday. The company has a market cap of $90.40 billion, a price-to-earnings ratio of 16.71, a PEG ratio of 1.31 and a beta of 1.47. The firm's 50-day moving average is $375.13 and its 200-day moving average is $341.72. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 1.06 and a current ratio of 1.19.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.36 earnings per share. Equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Monday, June 16th were paid a dividend of $0.72 per share. The ex-dividend date was Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.77%. HCA Healthcare's dividend payout ratio is 12.81%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Guggenheim assumed coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Wells Fargo & Company raised shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and boosted their target price for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $404.00 target price (up previously from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Seven equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus price target of $395.71.

Get Our Latest Report on HCA

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer directly owned 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HCA Healthcare Right Now?

Before you consider HCA Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.

While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain
Triple-Digit Gains: These 4 Nuclear Stocks Have Even More Upside Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines